- Biomarkers for Severe Asthma: Lessons From Longitudinal Cohort StudiesYoungsoo, Lee; Quang Luu, Quoc; Hae-Sim, ParkAllergy Asthma & Immunology Research, 2021, 13(3): 375.
- Risk Factors Predicting Severe Asthma Exacerbations in Adult Asthmatics: A Real-World Clinical EvidenceGa-Young, Ban; Su-Chin, Kim; Hyun Young, Lee; Young-Min, Ye; Yoo Seob, Shin; Hae-Sim, ParkAllergy Asthma & Immunology Research, 2021, 13(3): 420.
- Severe eosinophilic asthma in Chinese C-BIOPRED asthma cohortZhang, Qingling; Fu, Xiuhua; Wang, Changzheng; Shen, Huahao; Zhu, Lei; Shi, Guochao; Qiu, Zhongmin; Wen, Zhongguang; Gu, Wei; Luo, Wei; Zhao, Lina; Chen, Yunqin; Lim, Sam; Xiao, Chang; Kang, Jian; Zhang, Yunhui; Huang, Mao; Xu, Jinfu; Huang, Kewu; Li, Qiang; Zhang, Xiangyan; Zhao, Jianping; Liu, Xiaoxia; Sun, Shenghua; Tang, Huaping; He, Bei; Cai, Shaoxi; Chen, Ping; Wei, Chunhua; Wang, Guangfa; Chen, Ping; Xie, Lixin; Lin, Jiangtao; Tang, Yuling; Han, Zhihai; Chung, Kian Fan*Clinical and Translational Medicine, 2022, 12(2): e710.被引 3
期刊论文
Eligibility of C-BIOPRED severe asthma cohort for type-2 biologic therapies
1被引16阅读
